Computational Assessment of Spectral Heterogeneity within Fresh Glioblastoma Tissue Using Raman Spectroscopy and Machine Learning Algorithms.
Karoline KleinGilbert Georg KlammingerLaurent MombaertsFinn JelkeIsabel Fernandes ArroteiaRédouane SlimaniGiulia MirizziAndreas HuschKatrin B M FrauenknechtMichel MittelbronnFrank HertelFelix B Kleine BorgmannPublished in: Molecules (Basel, Switzerland) (2024)
Understanding and classifying inherent tumor heterogeneity is a multimodal approach, which can be undertaken at the genetic, biochemical, or morphological level, among others. Optical spectral methods such as Raman spectroscopy aim at rapid and non-destructive tissue analysis, where each spectrum generated reflects the individual molecular composition of an examined spot within a (heterogenous) tissue sample. Using a combination of supervised and unsupervised machine learning methods as well as a solid database of Raman spectra of native glioblastoma samples, we succeed not only in distinguishing explicit tumor areas-vital tumor tissue and necrotic tumor tissue can correctly be predicted with an accuracy of 76%-but also in determining and classifying different spectral entities within the histomorphologically distinct class of vital tumor tissue. Measurements of non-pathological, autoptic brain tissue hereby serve as a healthy control since their respective spectroscopic properties form an individual and reproducible cluster within the spectral heterogeneity of a vital tumor sample. The demonstrated decipherment of a spectral glioblastoma heterogeneity will be valuable, especially in the field of spectroscopically guided surgery to delineate tumor margins and to assist resection control.
Keyphrases
- machine learning
- raman spectroscopy
- optical coherence tomography
- single cell
- artificial intelligence
- minimally invasive
- deep learning
- high resolution
- computed tomography
- mass spectrometry
- molecular dynamics
- magnetic resonance imaging
- molecular docking
- white matter
- single molecule
- pain management
- chronic pain
- adverse drug